Related Experiment Video

Updated: May 28, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
10:13

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples

Published on: December 2, 2022

[Molecular determinants of response to topoisomerase II inhibitors]

Amélie Lansiaux1, Philippe Pourquier

  • 1Centre Oscar Lambret, Université Lille Nord de France. a-Lansiaux@o-lambret.fr

Bulletin Du Cancer
|October 26, 2011
PubMed

Insights

Human topoisomerases II (Top2) are crucial for DNA management and are targeted by anticancer drugs. Understanding resistance mechanisms and side effects is key to developing improved Top2 inhibitors and personalized cancer treatments.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Human nuclear topoisomerases II (Top2) regulate DNA supercoiling, chromosome segregation, and chromatin remodeling.
  • Top2 are established targets for anticancer drug development, with inhibitors like anthracyclines and epipodophyllotoxins in clinical use.

Purpose of the Study:

  • To explore the mechanisms of resistance to Top2 inhibitors.
  • To identify biomarkers for predicting patient response to Top2-targeted therapies.
  • To address the clinical issue of secondary malignancies associated with Top2β poisoning.

Main Methods:

  • Review of existing literature on Top2 function, inhibitors, and resistance mechanisms.
  • Analysis of drug-induced DNA damage and repair pathways.
  • Investigation of Top2β-related toxicities.

Main Results:

  • Top2 inhibitors function by either poisoning Top2 at DNA cleavage sites, causing double-strand breaks, or by inhibiting Top2's catalytic activity.
  • Resistance to Top2 inhibitors involves complex mechanisms including drug transport, metabolism, DNA damage signaling, and repair.
  • Top2β poisoning can lead to secondary malignancies, posing a significant clinical challenge.

Conclusions:

  • A deeper understanding of Top2 inhibitor resistance and toxicity is essential for advancing cancer therapy.
  • Developing novel Top2 inhibitors and predictive biomarkers will enable more effective and personalized patient treatments.

More Related Videos

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...